[go: up one dir, main page]

WO2005043111A3 - Marqueurs biologiques seriques pour le sras - Google Patents

Marqueurs biologiques seriques pour le sras Download PDF

Info

Publication number
WO2005043111A3
WO2005043111A3 PCT/US2004/022777 US2004022777W WO2005043111A3 WO 2005043111 A3 WO2005043111 A3 WO 2005043111A3 US 2004022777 W US2004022777 W US 2004022777W WO 2005043111 A3 WO2005043111 A3 WO 2005043111A3
Authority
WO
WIPO (PCT)
Prior art keywords
sars
biomarkers
serum biomarkers
present
combinations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2004/022777
Other languages
English (en)
Other versions
WO2005043111A2 (fr
Inventor
Xixiong Kang
Hong Tang
Xiaoyi Wu
Eric Fung
Junhua Guo
Yang Xu
Fujun Zhang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aspira Womens Health Inc
Original Assignee
Ciphergen Biosystems Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciphergen Biosystems Inc filed Critical Ciphergen Biosystems Inc
Publication of WO2005043111A2 publication Critical patent/WO2005043111A2/fr
Anticipated expiration legal-status Critical
Publication of WO2005043111A3 publication Critical patent/WO2005043111A3/fr
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/165—Coronaviridae, e.g. avian infectious bronchitis virus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)

Abstract

L'invention concerne des marqueurs biologiques et des combinaisons de marqueurs biologiques permettant de déterminer la présence du SRAS chez un patient. L'invention concerne en outre une méthodologie diagnostique comprenant l'utilisation de ces marqueurs biologiques et des combinaisons de ceux-ci, et permettant de distinguer le SRAS de l'état normal.
PCT/US2004/022777 2003-07-14 2004-07-14 Marqueurs biologiques seriques pour le sras Ceased WO2005043111A2 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US48746903P 2003-07-14 2003-07-14
US60/487,469 2003-07-14
US51034103P 2003-10-10 2003-10-10
US60/510,341 2003-10-10

Publications (2)

Publication Number Publication Date
WO2005043111A2 WO2005043111A2 (fr) 2005-05-12
WO2005043111A3 true WO2005043111A3 (fr) 2009-03-26

Family

ID=34555575

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2004/022777 Ceased WO2005043111A2 (fr) 2003-07-14 2004-07-14 Marqueurs biologiques seriques pour le sras

Country Status (1)

Country Link
WO (1) WO2005043111A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1740957B1 (fr) * 2004-04-20 2014-03-12 SphingoTec GmbH Utilisation de precurseurs de tachykinines et/ou de fragments de celles-ci dans un diagnostic medical
WO2007053165A2 (fr) * 2005-01-11 2007-05-10 Yale University Biopuce a proteines virales et ses utilisations
CN114858906B (zh) * 2021-02-04 2024-08-09 北京毅新博创生物科技有限公司 用于诊断新型冠状病毒感染的试剂盒

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
KROKHIN 0 ET AL.: "Mass spectrometric characterization of proteins from the SARS virus: a preliminary report", MOL CELL PROTEOMICS., vol. 2, no. 5, May 2003 (2003-05-01), pages 346 - 56 *

Also Published As

Publication number Publication date
WO2005043111A2 (fr) 2005-05-12

Similar Documents

Publication Publication Date Title
WO2004061410A3 (fr) Biomarqueurs seriques du cancer du poumon
WO2007008276A3 (fr) Sondes a renouvellement et utilisation
WO2008082987A3 (fr) Protections et méthodes pour appareils de mesure de substances à analyser
GB2441243B8 (en) Block acknowledgements with reduced recipient state information.
WO2006036633A3 (fr) Systeme de type stent cilie
WO2005057166A3 (fr) Detection de proteines et de prions alteres de maniere conformationnelle
WO2007112279A3 (fr) Résonateurs
AU2007266218B2 (en) Biomarkers for diagnosing multiple sclerosis, and methods thereof
WO2004094667A3 (fr) Reactifs et methodes permettant de detecter le coronavirus responsable du syndrome respiratoire aigu severe
WO2006009649A3 (fr) Sequences de brassica indehiscent1
AU2002324881A1 (en) Diagnostic and prognostic tests
WO2005087793A3 (fr) Compositions immunostimulatrices et leurs utilisations
WO2004111654A3 (fr) Biomarqueurs de serum dans une maladie cardiaque ischemique
WO2007067435A3 (fr) Filaments a deux constituants de poly(trimethylene terephtalate)/poly(acide alpha-hydroxy)
WO2005013809A3 (fr) Diagnostic et therapeutique pour l'osteoporose
WO2007048084A3 (fr) Analyse judiciaire de salive humaine
WO2007067433A3 (fr) Films de poly(trimethylene terephtalate)/poly(acide alpha-hydroxy)
WO2005043111A3 (fr) Marqueurs biologiques seriques pour le sras
WO2005007893A3 (fr) Detection universelle de liaison
WO2005037859A3 (fr) Essai de fluorescence permettant de determiner l'activite d'une kinase
ITTO20050784A1 (it) Ruota per veicoli e procedimento per la sua realizzazione.
WO2004081537A3 (fr) Procedes d'evaluation de restriction calorique et d'identification d'agents mimetiques de restriction calorique
WO2007075672A3 (fr) Marqueurs pour le pronostic du cancer
AU2001242507A1 (en) Method, diagnostic kit and microarray for determining the rhesus factor
WO2006104761A3 (fr) Sondes d'hybridation unisequentielles

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase